Catherine Slota1, Robyn Sayner, Michelle Vitko, Delesha M Carpenter, Susan J Blalock, Alan L Robin, Kelly W Muir, Mary Elizabeth Hartnett, Betsy Sleath. 1. *PhD †PharmD ‡BA §PhD, MSPH ∥MD Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (CS, RS, MV, DMC, SJB, BS); Department of Ophthalmology, University of Maryland, Baltimore, Maryland (ALR); Department of Ophthalmology University of Michigan, Ann Arbor, Michigan (ALR); Department of International Health, Bloomberg School of Public Health, Baltimore, Maryland (ALR); Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, Maryland (ALR); Department of Ophthalmology, School of Medicine, Duke University, Durham, North Carolina (KWM); Durham VA Medical Center, Health Services Research and Development, Durham, North Carolina (KWM); Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center University of Utah, Salt Lake City, Utah (MEH); and Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (BS).
Abstract
PURPOSE: The purpose of this study was to examine if patient demographic factors influenced self-reporting of medication side effects, difficulty with drop instillation, and nonadherence to glaucoma therapy. METHODS: English-speaking adult glaucoma patients (n = 279) from six ophthalmology clinics were enrolled. Patients' medical visits were videotaped and patients were interviewed immediately afterward by research assistants. The videotapes were transcribed verbatim and coded to identify patients who expressed problems with medication side effects, eye drop administration, and nonadherence during the glaucoma office visits. Generalized estimating equations were performed to identify whether patient characteristics were associated with expression of problems with glaucoma medication and medication nonadherence during the office visit. RESULTS: Patients with lower health literacy were significantly less likely to express problems with side effects (odds ratio [OR], 0.47; 95% confidence interval [CI], 0.25 to 0.88) and eye drop administration (OR, 0.26; 95% CI, 0.11 to 0.63) during the visit. Patients who reported eye drop administration and side effect problems during the interview were significantly more likely to express these problems to their ophthalmologist (OR, 3.13; 95% CI, 1.82 to 5.37 and OR, 1.86; 95% CI, 1.12 to 3.08, respectively). Patients who expressed a problem with eye drop administration and with side effects were significantly more likely to express medication nonadherence to their ophthalmologist (OR, 2.89; 95% CI, 1.44 to 5.80 and OR, 2.03; 95% CI, 1.16 to 3.54, respectively). Patients who reported greater than 80% medication adherence during the interview were significantly less likely to express nonadherence to their ophthalmologist (OR, 0.22; 95% CI, 0.12 to 0.40). CONCLUSIONS: Eye care providers should be aware that glaucoma patients with lower health literacy are less likely to express problems with side effects and eye drop administration. Providers should work with patients to assess medication-related problems to mitigate potential barriers to medication adherence because patients who expressed medication problems were also more likely to express nonadherence.
PURPOSE: The purpose of this study was to examine if patient demographic factors influenced self-reporting of medication side effects, difficulty with drop instillation, and nonadherence to glaucoma therapy. METHODS: English-speaking adult glaucomapatients (n = 279) from six ophthalmology clinics were enrolled. Patients' medical visits were videotaped and patients were interviewed immediately afterward by research assistants. The videotapes were transcribed verbatim and coded to identify patients who expressed problems with medication side effects, eye drop administration, and nonadherence during the glaucoma office visits. Generalized estimating equations were performed to identify whether patient characteristics were associated with expression of problems with glaucoma medication and medication nonadherence during the office visit. RESULTS:Patients with lower health literacy were significantly less likely to express problems with side effects (odds ratio [OR], 0.47; 95% confidence interval [CI], 0.25 to 0.88) and eye drop administration (OR, 0.26; 95% CI, 0.11 to 0.63) during the visit. Patients who reported eye drop administration and side effect problems during the interview were significantly more likely to express these problems to their ophthalmologist (OR, 3.13; 95% CI, 1.82 to 5.37 and OR, 1.86; 95% CI, 1.12 to 3.08, respectively). Patients who expressed a problem with eye drop administration and with side effects were significantly more likely to express medication nonadherence to their ophthalmologist (OR, 2.89; 95% CI, 1.44 to 5.80 and OR, 2.03; 95% CI, 1.16 to 3.54, respectively). Patients who reported greater than 80% medication adherence during the interview were significantly less likely to express nonadherence to their ophthalmologist (OR, 0.22; 95% CI, 0.12 to 0.40). CONCLUSIONS: Eye care providers should be aware that glaucomapatients with lower health literacy are less likely to express problems with side effects and eye drop administration. Providers should work with patients to assess medication-related problems to mitigate potential barriers to medication adherence because patients who expressed medication problems were also more likely to express nonadherence.
Authors: Kelly W Muir; Cecile Santiago-Turla; Sandra S Stinnett; Leon W Herndon; R Rand Allingham; Pratap Challa; Paul P Lee Journal: Am J Ophthalmol Date: 2006-08 Impact factor: 5.258
Authors: Betsy Sleath; Alan L Robin; David Covert; John E Byrd; Gail Tudor; Bonnie Svarstad Journal: Ophthalmology Date: 2006-02-03 Impact factor: 12.079
Authors: David P Nau; Douglas T Steinke; L Keoki Williams; Roger Austin; Jennifer Elston Lafata; George Divine; Manel Pladevall Journal: Ann Pharmacother Date: 2007-10-09 Impact factor: 3.154
Authors: Betsy L Sleath; Susan J Blalock; Kelly W Muir; Delesha M Carpenter; Scott D Lawrence; Annette L Giangiacomo; Jason A Goldsmith; Mary Elizabeth Hartnett; Catherine Slota; Alan L Robin Journal: Ann Pharmacother Date: 2014-04-01 Impact factor: 3.154
Authors: Betsy L Sleath; R Krishnadas; Minhee Cho; Alan L Robin; Rakhi Mehta; David Covert; Gail Tudor Journal: Indian J Ophthalmol Date: 2009 Jan-Feb Impact factor: 1.848
Authors: Alison E Fohner; Dilrini K Ranatunga; Khanh K Thai; Brian L Lawson; Neil Risch; Akinyemi Oni-Orisan; Aline T Jelalian; Allan E Rettie; Vincent X Liu; Catherine A Schaefer Journal: Pharmacogenet Genomics Date: 2019-10 Impact factor: 2.089
Authors: Scott J Fudemberg; Dilru C Amarasekera; Marlee H Silverstein; Kathryn M Linder; Paul Heffner; Lisa A Hark; Michael Waisbourd Journal: J Community Health Date: 2016-08
Authors: Eva K Fenwick; Belicia Lim; Ryan E K Man; Mani Baskaran; Monisha E Nongpiur; Chelvin C A Sng; Jayant V Iyer; Rahat Husain; Shamira A Perera; Tina T Wong; Jin Rong Low; Olivia Huang Shimin; Katherine Lun; Tin Aung; Ecosse L Lamoureux Journal: J Patient Rep Outcomes Date: 2022-10-11